Thoracic Oncology
The clinical research activity includes malignant pleural mesothelioma, with interest in treatment strategies for resectable disease and the integration of immunotherapy with platinum-based chemotherapy.
- Malignant pleural mesothelioma
- Pembrolizumab combinations
- Cisplatin and carboplatin-based therapy
- Pemetrexed
Research activity is centered on epithelioid and biphasic pleural mesothelioma, reflecting a focus on perioperative systemic treatment in thoracic malignancy.
Neuro-Oncology
The sponsor supports studies in MGMT-methylated, IDH wild-type glioblastoma, with attention to treatment approaches for newly diagnosed aggressive brain tumors.
- Glioblastoma
- Temozolomide-based therapy
- Radiotherapy
- Combination systemic treatment
These trials reflect a therapeutic interest in high-grade glioma management and multimodal treatment options in neuro-oncology.
Neuro-Oncology for Meningioma
Clinical investigations also address grade 1, 2 and 3 meningioma, with emphasis on recurrent and progressive disease after local treatment.
- Recurrent meningioma
- Grade 2 meningioma
- Grade 3 meningioma
- Regorafenib
The work includes interest in systemic options for meningioma progression, particularly in patients with disease recurrence following surgery and radiotherapy.
